Assessment of oral antithrombotic therapy by platelet function testing (Q37902507)

25 August 2017

1 reference

title

Assessment of oral antithrombotic therapy by platelet function testing (English)

1 reference

25 August 2017

Udaya S Tantry

1

1 reference

PubMed ID

21769112

25 August 2017

Paul A Gurbel

series ordinal

2

1 reference

PubMed ID

21769112

25 August 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

Nature Reviews Cardiology

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

10

1 reference

25 August 2017

572-579

1 reference

Antiplatelet therapy: current strategies and future trends

25 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Combining antiplatelet and anticoagulant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet function monitoring in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Laboratory evaluation of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clinical utility of thromboelastography: one size does not fit all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

The incremental value of thrombelastography for prediction of excessive blood loss after cardiac surgery: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clinical utility of the PFA-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Near-patient platelet function testing in patients undergoing coronary artery surgery: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

RETRACTED: Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer--comparison with two flow cytometric methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.107

Thromboelastography and cardiopulmonary bypass.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21769112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Simulation of primary haemostasis in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21769112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21769112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2011.107

1 reference

25 August 2017

1 reference

PubMed ID

21769112